Hematology Analysers Market- Global Industry Analysis and Forecast (2023-2029)

Global Hematology Analysers Market is expected to grow at a CAGR of 4.8% during the forecast period. Global Hematology Analysers Market is expected to reach US$ 12.31 Bn. by 2029.

The report includes an analysis of the impact of COVID-19 lockdown on the revenue of market leaders, followers, and disruptors. Since the lockdown was implemented differently in various regions and countries; the impact of the same is also seen differently by regions and segments. The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region.To Know About The Research Methodology :- Request Free Sample Report
Global Hematology Analysers Market: Introduction
During the last quarter-century, blood-cell analysis has progressed from the use of labor-intensive manual procedures to the use of highly automated instruments capable of measuring many disease-associated parameters. Modern hematology analyzers incorporate non-traditional flow cytometry, robotics, and expert system technologies. Hematology instruments range from handheld photo-optical devices to sophisticated, highly automated analyzers.
Global Hematology Analysers Market: Dynamics
The major factors for the growth of the hematology analyzers market include the rising burden of blood disorders, increasing technological advancements, and rising adoption rates of automated hematology instruments.

Blood disorders have become a global health issue with different causes, and are associated with high mortality. Blood disorders, such as anemia, blood cancers, hemorrhagic conditions, and infections in the blood, affect millions of people each year across all age groups.

According to Commonwealth of Australia, more than 330,000 affected infants are born each year (83% sickle cell disorders and 17% thalassemia’s), around 7% of pregnant women are carriers of hemoglobin disorders and over 1% of couples are at risk at a global level. As per the World Federation of Haemophilia, in 2022, the prevalence of hemophilia among men was found to be around 17 per 100,000 males, globally. Early diagnosis and treatment are the best ways to protect the quality of life for a patient with a blood cell disorder. Hence, the increasing burden of blood disorders is likely to drive the market in the future. Factors attributing towards the dominance of clinical testing labs division are chronic lead poisoning and sickle cell disease, increasing the prevalence of blood-related disorders such as hereditary spherocytosis, cytochemistries on blood and bone marrow, identification of abnormal haemoglobin’s, and chronic granulomatous disease.
Global Hematology Analysers Market: Segment Analysis
By end-user, Hematology Analysers market is segmented as- Stand-alone hospitals, Clinical testing labs, Research institutes and Commercial organizations. The Hematology Laboratory/clinics provide routine hematology assays for patients and specialty hematology testing for both the Medical Center and Outreach. Standard consultative diagnostics in the Hematology Laboratory include: reflex analysis of blood smears and cytopathologic examination of body fluids directed blood screening for parasites, laboratory evaluation of coagulopathies and hypercoagulability, identification of abnormal hemoglobins/thalassemia, cytochemistries on blood and bone marrow, specialty testing for hematologic and related diseases such as chronic granulomatous disease; hereditary spherocytosis; chronic lead poisoning; and sickle cell disease.

The hospital segment is expected to register a CAGR of xx% during the forecast period. Hospitals held a leading revenue share of xx% in the Lymphoma Market in 2022. Surgeries and other operations are performed majorly in hospitals, due to the availability of all tools and technologies required. Treatment procedures conducted in hospitals or hospital-attached outpatient facilities enable ease of handling any emergency situations that may arise.
Global Hematology Analysers Market: Regional Insights
Based on regions, North America registered the highest growth in the hematology analyzers market and is expected to continue the same in the forecast period. The increasing number of patients suffering from blood-related diseases, high disposable income, growing demand for blood transfusions, and the adoption of advanced technology-based hematology devices are the factors responsible for market growth.

Following North America, Asia Pacific is also expected to experience growth in the coming years due to the presence of a largely untapped opportunity that the manufacturers still need to explore. The other factors supporting the growth are improving healthcare structure and growing investments by different organizations and manufacturers towards the development of hematology products. The allocation of a large amount of healthcare expenditure for hospitals and dispensing medicines to the elderly is expected to drive the market demand.
Hematology Analysers Market Scope :Inquiry before Buying



Hematology Analysers Market


Report Coverage
Details


Base Year:
2022
Forecast Period:
2023-2029


Historical Data:
2018 to 2022
Market Size in 2022:
US $ 8.86 Bn.


Forecast Period 2023 to 2029 CAGR:
4.8%
Market Size in 2029:
US $ 12.31 Bn.


 Segments Covered:
by Product
Consumable
Instruments


by End-User
Stand-alone Hospital
Clinical Testing Labs
Research institutes
Commercial Organization


by Product & Service
Instruments
Reagents & Consumables
Services



Global Hematology Analysers Market: By Region
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
North America (United States, Canada and Mexico)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Global Hematology Analysers Market: Key Players
1. Abbott Laboratories
2. Danaher Corporation
3. Beckman Coulter
4. HORIBA Ltd
5. Siemens AG
6. Sysmex Corporation
7. Nihon Kohden Corporation
8. Bio-Rad Laboratories
9. Mindray Medical International Ltd.
10. Roche Diagnostics
11. Diagnostics AB
12. Boule Diagnostics
13. Diatron
14. Drew Scientific
15. EKF Diagnostics
16. Ortho Clinical Diagnostics

Frequently Asked Questions:

1. Which region has the largest share in Global Hematology Analysers market?
Ans: Asia Pacific region holds the highest share in 2022.

2. What is the growth rate of Global Hematology Analysers market?
Ans: The Global Hematology Analysers Market is growing at a CAGR of 4.8% during forecasting period 2023-2029.

3. What is scope of the Global Hematology Analysers market report?
Ans: Global Hematology Analysers Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. What is the study period of this market?
Ans: The Global Hematology Analysers Market is studied from 2022 to 2029.